nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—PTGFR—corpus luteum—ovarian cancer	0.0622	0.157	CbGeAlD
Dinoprost Tromethamine—PTGFR—ovarian follicle—ovarian cancer	0.0486	0.123	CbGeAlD
Dinoprost Tromethamine—GALR3—uterus—ovarian cancer	0.0122	0.0307	CbGeAlD
Dinoprost Tromethamine—GALR3—female reproductive system—ovarian cancer	0.0109	0.0276	CbGeAlD
Dinoprost Tromethamine—TBXA2R—epithelium—ovarian cancer	0.00872	0.022	CbGeAlD
Dinoprost Tromethamine—PTGER3—myometrium—ovarian cancer	0.00855	0.0216	CbGeAlD
Dinoprost Tromethamine—TBXA2R—decidua—ovarian cancer	0.00824	0.0208	CbGeAlD
Dinoprost Tromethamine—HPGDS—myometrium—ovarian cancer	0.00739	0.0186	CbGeAlD
Dinoprost Tromethamine—HPGDS—embryo—ovarian cancer	0.00711	0.0179	CbGeAlD
Dinoprost Tromethamine—PTGFR—myometrium—ovarian cancer	0.00684	0.0172	CbGeAlD
Dinoprost Tromethamine—TBXA2R—female reproductive system—ovarian cancer	0.00648	0.0163	CbGeAlD
Dinoprost Tromethamine—TBXA2R—vagina—ovarian cancer	0.00586	0.0148	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—ovarian cancer	0.0058	0.0146	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterine cervix—ovarian cancer	0.00575	0.0145	CbGeAlD
Dinoprost Tromethamine—PTGER1—female reproductive system—ovarian cancer	0.00569	0.0143	CbGeAlD
Dinoprost Tromethamine—PTGER3—uterus—ovarian cancer	0.00555	0.014	CbGeAlD
Dinoprost Tromethamine—HPGDS—decidua—ovarian cancer	0.00548	0.0138	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—myometrium—ovarian cancer	0.00532	0.0134	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—myometrium—ovarian cancer	0.00527	0.0133	CbGeAlD
Dinoprost Tromethamine—TBXA2R—testis—ovarian cancer	0.00523	0.0132	CbGeAlD
Dinoprost Tromethamine—HPGDS—endometrium—ovarian cancer	0.0052	0.0131	CbGeAlD
Dinoprost Tromethamine—PTGER1—female gonad—ovarian cancer	0.00517	0.0131	CbGeAlD
Dinoprost Tromethamine—PTGER3—female reproductive system—ovarian cancer	0.00499	0.0126	CbGeAlD
Dinoprost Tromethamine—HPGDS—gonad—ovarian cancer	0.00483	0.0122	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterus—ovarian cancer	0.00479	0.0121	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—ovarian cancer	0.00473	0.0119	CbGeAlD
Dinoprost Tromethamine—PTGER3—female gonad—ovarian cancer	0.00454	0.0114	CbGeAlD
Dinoprost Tromethamine—PTGFR—uterus—ovarian cancer	0.00443	0.0112	CbGeAlD
Dinoprost Tromethamine—HPGDS—female reproductive system—ovarian cancer	0.00431	0.0109	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—uterine cervix—ovarian cancer	0.00414	0.0104	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—ovarian cancer	0.00413	0.0104	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterine cervix—ovarian cancer	0.0041	0.0103	CbGeAlD
Dinoprost Tromethamine—HPGDS—bone marrow—ovarian cancer	0.00407	0.0103	CbGeAlD
Dinoprost Tromethamine—PTGER3—testis—ovarian cancer	0.00402	0.0101	CbGeAlD
Dinoprost Tromethamine—PTGFR—female reproductive system—ovarian cancer	0.00399	0.0101	CbGeAlD
Dinoprost Tromethamine—PTGIR—gonad—ovarian cancer	0.00393	0.00992	CbGeAlD
Dinoprost Tromethamine—HPGDS—female gonad—ovarian cancer	0.00392	0.00989	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—decidua—ovarian cancer	0.00391	0.00985	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—ovarian cancer	0.0039	0.00983	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—ovarian cancer	0.00379	0.00956	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—endometrium—ovarian cancer	0.00371	0.00935	CbGeAlD
Dinoprost Tromethamine—PTGFR—female gonad—ovarian cancer	0.00363	0.00915	CbGeAlD
Dinoprost Tromethamine—PTGIR—female reproductive system—ovarian cancer	0.00351	0.00886	CbGeAlD
Dinoprost Tromethamine—HPGDS—testis—ovarian cancer	0.00348	0.00877	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—gonad—ovarian cancer	0.00347	0.00876	CbGeAlD
Dinoprost Tromethamine—SLC22A11—female reproductive system—ovarian cancer	0.00342	0.00863	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterus—ovarian cancer	0.00342	0.00862	CbGeAlD
Dinoprost Tromethamine—PTGFR—testis—ovarian cancer	0.00322	0.00811	CbGeAlD
Dinoprost Tromethamine—PTGIR—female gonad—ovarian cancer	0.0032	0.00806	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female reproductive system—ovarian cancer	0.0031	0.00782	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female reproductive system—ovarian cancer	0.00307	0.00774	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—ovarian cancer	0.00292	0.00736	CbGeAlD
Dinoprost Tromethamine—PTGIR—testis—ovarian cancer	0.00284	0.00715	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female gonad—ovarian cancer	0.00282	0.00712	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—ovarian cancer	0.0028	0.00707	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female gonad—ovarian cancer	0.00279	0.00705	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—vagina—ovarian cancer	0.00278	0.007	CbGeAlD
Dinoprost Tromethamine—SLC22A7—testis—ovarian cancer	0.0027	0.0068	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—ovarian cancer	0.00252	0.00636	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—testis—ovarian cancer	0.0025	0.00631	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—testis—ovarian cancer	0.00248	0.00625	CbGeAlD
Dinoprost Tromethamine—PTGFR—lymph node—ovarian cancer	0.00233	0.00588	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—ovarian cancer	0.00206	0.00518	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lymph node—ovarian cancer	0.00181	0.00457	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—ovarian cancer	0.0018	0.00453	CbGeAlD
Dinoprost Tromethamine—Hypotension—Melphalan—ovarian cancer	0.0011	0.00257	CcSEcCtD
Dinoprost Tromethamine—Cough—Vinorelbine—ovarian cancer	0.0011	0.00257	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Vinorelbine—ovarian cancer	0.00108	0.00254	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Topotecan—ovarian cancer	0.00108	0.00252	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Vinorelbine—ovarian cancer	0.00107	0.0025	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Topotecan—ovarian cancer	0.00107	0.0025	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Chlorambucil—ovarian cancer	0.00106	0.00249	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Chlorambucil—ovarian cancer	0.00106	0.00249	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Vinorelbine—ovarian cancer	0.00106	0.00247	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Melphalan—ovarian cancer	0.00105	0.00247	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Paclitaxel—ovarian cancer	0.00105	0.00246	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Melphalan—ovarian cancer	0.00105	0.00245	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Paclitaxel—ovarian cancer	0.00103	0.00241	CcSEcCtD
Dinoprost Tromethamine—Pain—Topotecan—ovarian cancer	0.00102	0.0024	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00102	0.00239	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—ovarian cancer	0.00102	0.00239	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Paclitaxel—ovarian cancer	0.00102	0.00239	CcSEcCtD
Dinoprost Tromethamine—Infection—Vinorelbine—ovarian cancer	0.00102	0.00239	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Docetaxel—ovarian cancer	0.00101	0.00237	CcSEcCtD
Dinoprost Tromethamine—Pain—Melphalan—ovarian cancer	0.001	0.00235	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Vinorelbine—ovarian cancer	0.001	0.00234	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000991	0.00232	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Paclitaxel—ovarian cancer	0.000987	0.00231	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Topotecan—ovarian cancer	0.000987	0.00231	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000979	0.0023	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Epirubicin—ovarian cancer	0.000968	0.00227	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Chlorambucil—ovarian cancer	0.000965	0.00226	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Epirubicin—ovarian cancer	0.000958	0.00225	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Vinorelbine—ovarian cancer	0.000957	0.00224	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Chlorambucil—ovarian cancer	0.000952	0.00223	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Topotecan—ovarian cancer	0.000947	0.00222	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Topotecan—ovarian cancer	0.000947	0.00222	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Epirubicin—ovarian cancer	0.00093	0.00218	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Epirubicin—ovarian cancer	0.000926	0.00217	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—ovarian cancer	0.000921	0.00216	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Chlorambucil—ovarian cancer	0.00092	0.00216	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Vinorelbine—ovarian cancer	0.00092	0.00216	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Vinorelbine—ovarian cancer	0.000913	0.00214	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—ovarian cancer	0.000895	0.0021	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—ovarian cancer	0.000886	0.00208	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000884	0.00207	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Topotecan—ovarian cancer	0.000882	0.00207	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Paclitaxel—ovarian cancer	0.00088	0.00206	CcSEcCtD
Dinoprost Tromethamine—Pain—Vinorelbine—ovarian cancer	0.000876	0.00205	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Paclitaxel—ovarian cancer	0.000876	0.00205	CcSEcCtD
Dinoprost Tromethamine—Chills—Paclitaxel—ovarian cancer	0.00087	0.00204	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Melphalan—ovarian cancer	0.000864	0.00202	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Docetaxel—ovarian cancer	0.000864	0.00202	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—ovarian cancer	0.000861	0.00202	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Topotecan—ovarian cancer	0.000859	0.00201	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000857	0.00201	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Chlorambucil—ovarian cancer	0.000855	0.002	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000853	0.002	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Topotecan—ovarian cancer	0.000847	0.00199	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000844	0.00198	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Melphalan—ovarian cancer	0.000841	0.00197	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000838	0.00196	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Melphalan—ovarian cancer	0.00083	0.00194	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Topotecan—ovarian cancer	0.000819	0.00192	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000818	0.00192	CcSEcCtD
Dinoprost Tromethamine—Back pain—Paclitaxel—ovarian cancer	0.000817	0.00191	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Paclitaxel—ovarian cancer	0.000812	0.0019	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vinorelbine—ovarian cancer	0.00081	0.0019	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Vinorelbine—ovarian cancer	0.00081	0.0019	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Melphalan—ovarian cancer	0.000802	0.00188	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—ovarian cancer	0.000801	0.00188	CcSEcCtD
Dinoprost Tromethamine—Nausea—Chlorambucil—ovarian cancer	0.000799	0.00187	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Topotecan—ovarian cancer	0.000792	0.00186	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000783	0.00184	CcSEcCtD
Dinoprost Tromethamine—Agitation—Paclitaxel—ovarian cancer	0.000776	0.00182	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—ovarian cancer	0.000762	0.00179	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Topotecan—ovarian cancer	0.000761	0.00178	CcSEcCtD
Dinoprost Tromethamine—Malaise—Paclitaxel—ovarian cancer	0.000761	0.00178	CcSEcCtD
Dinoprost Tromethamine—Syncope—Paclitaxel—ovarian cancer	0.000757	0.00177	CcSEcCtD
Dinoprost Tromethamine—Rash—Topotecan—ovarian cancer	0.000755	0.00177	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000755	0.00177	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Topotecan—ovarian cancer	0.000754	0.00177	CcSEcCtD
Dinoprost Tromethamine—Headache—Topotecan—ovarian cancer	0.00075	0.00176	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Docetaxel—ovarian cancer	0.000746	0.00175	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Melphalan—ovarian cancer	0.000745	0.00175	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—ovarian cancer	0.000745	0.00175	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Docetaxel—ovarian cancer	0.000742	0.00174	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000742	0.00174	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—ovarian cancer	0.000742	0.00174	CcSEcCtD
Dinoprost Tromethamine—Rash—Melphalan—ovarian cancer	0.000739	0.00173	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Melphalan—ovarian cancer	0.000739	0.00173	CcSEcCtD
Dinoprost Tromethamine—Chills—Docetaxel—ovarian cancer	0.000738	0.00173	CcSEcCtD
Dinoprost Tromethamine—Cough—Paclitaxel—ovarian cancer	0.000737	0.00173	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vinorelbine—ovarian cancer	0.000735	0.00172	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Paclitaxel—ovarian cancer	0.000731	0.00171	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—ovarian cancer	0.000729	0.00171	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Paclitaxel—ovarian cancer	0.000729	0.00171	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Vinorelbine—ovarian cancer	0.000725	0.0017	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Paclitaxel—ovarian cancer	0.000719	0.00168	CcSEcCtD
Dinoprost Tromethamine—Nausea—Topotecan—ovarian cancer	0.000711	0.00167	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Paclitaxel—ovarian cancer	0.00071	0.00166	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000705	0.00165	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vinorelbine—ovarian cancer	0.000701	0.00164	CcSEcCtD
Dinoprost Tromethamine—Nausea—Melphalan—ovarian cancer	0.000696	0.00163	CcSEcCtD
Dinoprost Tromethamine—Back pain—Docetaxel—ovarian cancer	0.000692	0.00162	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—ovarian cancer	0.00069	0.00162	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Docetaxel—ovarian cancer	0.000688	0.00161	CcSEcCtD
Dinoprost Tromethamine—Infection—Paclitaxel—ovarian cancer	0.000684	0.0016	CcSEcCtD
Dinoprost Tromethamine—Shock—Paclitaxel—ovarian cancer	0.000678	0.00159	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vinorelbine—ovarian cancer	0.000677	0.00159	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000675	0.00158	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Paclitaxel—ovarian cancer	0.000672	0.00158	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000666	0.00156	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vinorelbine—ovarian cancer	0.000651	0.00153	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—ovarian cancer	0.000648	0.00152	CcSEcCtD
Dinoprost Tromethamine—Rash—Vinorelbine—ovarian cancer	0.000646	0.00151	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vinorelbine—ovarian cancer	0.000645	0.00151	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Paclitaxel—ovarian cancer	0.000644	0.00151	CcSEcCtD
Dinoprost Tromethamine—Headache—Vinorelbine—ovarian cancer	0.000642	0.0015	CcSEcCtD
Dinoprost Tromethamine—Syncope—Docetaxel—ovarian cancer	0.000642	0.0015	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Docetaxel—ovarian cancer	0.000629	0.00147	CcSEcCtD
Dinoprost Tromethamine—Cough—Docetaxel—ovarian cancer	0.000624	0.00146	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Docetaxel—ovarian cancer	0.00062	0.00145	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Paclitaxel—ovarian cancer	0.000619	0.00145	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Docetaxel—ovarian cancer	0.000618	0.00145	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—ovarian cancer	0.000618	0.00145	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Paclitaxel—ovarian cancer	0.000614	0.00144	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Paclitaxel—ovarian cancer	0.000613	0.00144	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Docetaxel—ovarian cancer	0.000609	0.00143	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vinorelbine—ovarian cancer	0.000608	0.00143	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—ovarian cancer	0.0006	0.00141	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—ovarian cancer	0.000599	0.0014	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—ovarian cancer	0.000592	0.00139	CcSEcCtD
Dinoprost Tromethamine—Pain—Paclitaxel—ovarian cancer	0.000589	0.00138	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—ovarian cancer	0.000589	0.00138	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—ovarian cancer	0.000583	0.00137	CcSEcCtD
Dinoprost Tromethamine—Infection—Docetaxel—ovarian cancer	0.00058	0.00136	CcSEcCtD
Dinoprost Tromethamine—Shock—Docetaxel—ovarian cancer	0.000575	0.00135	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—ovarian cancer	0.000571	0.00134	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Docetaxel—ovarian cancer	0.00057	0.00134	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000568	0.00133	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—ovarian cancer	0.000564	0.00132	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000563	0.00132	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000555	0.0013	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—ovarian cancer	0.000548	0.00128	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Docetaxel—ovarian cancer	0.000546	0.00128	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—ovarian cancer	0.000545	0.00128	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Paclitaxel—ovarian cancer	0.000545	0.00128	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Paclitaxel—ovarian cancer	0.000545	0.00128	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—ovarian cancer	0.000539	0.00126	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Docetaxel—ovarian cancer	0.000524	0.00123	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—ovarian cancer	0.000522	0.00122	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Docetaxel—ovarian cancer	0.000521	0.00122	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Docetaxel—ovarian cancer	0.000519	0.00122	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000508	0.00119	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—ovarian cancer	0.000503	0.00118	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—ovarian cancer	0.000501	0.00117	CcSEcCtD
Dinoprost Tromethamine—Pain—Docetaxel—ovarian cancer	0.000499	0.00117	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—ovarian cancer	0.000497	0.00117	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Paclitaxel—ovarian cancer	0.000494	0.00116	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Paclitaxel—ovarian cancer	0.000487	0.00114	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Docetaxel—ovarian cancer	0.000481	0.00113	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000478	0.00112	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000471	0.0011	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—ovarian cancer	0.000467	0.00109	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—ovarian cancer	0.000465	0.00109	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—ovarian cancer	0.000464	0.00109	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—ovarian cancer	0.000463	0.00109	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Docetaxel—ovarian cancer	0.000462	0.00108	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Docetaxel—ovarian cancer	0.000462	0.00108	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—ovarian cancer	0.00046	0.00108	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Paclitaxel—ovarian cancer	0.000456	0.00107	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000448	0.00105	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—ovarian cancer	0.000444	0.00104	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Paclitaxel—ovarian cancer	0.000438	0.00103	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—ovarian cancer	0.000435	0.00102	CcSEcCtD
Dinoprost Tromethamine—Rash—Paclitaxel—ovarian cancer	0.000434	0.00102	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Paclitaxel—ovarian cancer	0.000434	0.00102	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—ovarian cancer	0.000433	0.00101	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—ovarian cancer	0.000432	0.00101	CcSEcCtD
Dinoprost Tromethamine—Headache—Paclitaxel—ovarian cancer	0.000432	0.00101	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Docetaxel—ovarian cancer	0.00043	0.00101	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—ovarian cancer	0.000429	0.00101	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—ovarian cancer	0.000424	0.000994	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—ovarian cancer	0.000421	0.000987	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Docetaxel—ovarian cancer	0.000419	0.000982	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—ovarian cancer	0.000418	0.00098	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—ovarian cancer	0.000417	0.000977	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000414	0.000971	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Docetaxel—ovarian cancer	0.000413	0.000968	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—ovarian cancer	0.000411	0.000963	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—ovarian cancer	0.00041	0.000962	CcSEcCtD
Dinoprost Tromethamine—Nausea—Paclitaxel—ovarian cancer	0.000409	0.000959	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—ovarian cancer	0.000406	0.000952	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—ovarian cancer	0.000403	0.000944	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—ovarian cancer	0.0004	0.000939	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Docetaxel—ovarian cancer	0.0004	0.000937	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000392	0.00092	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—ovarian cancer	0.000391	0.000917	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—ovarian cancer	0.00039	0.000913	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—ovarian cancer	0.000388	0.000908	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—ovarian cancer	0.000387	0.000907	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Docetaxel—ovarian cancer	0.000386	0.000905	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—ovarian cancer	0.000386	0.000904	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—ovarian cancer	0.000384	0.000901	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000381	0.000893	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—ovarian cancer	0.00038	0.000891	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—ovarian cancer	0.000376	0.00088	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Docetaxel—ovarian cancer	0.000371	0.00087	CcSEcCtD
Dinoprost Tromethamine—Rash—Docetaxel—ovarian cancer	0.000368	0.000863	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—ovarian cancer	0.000368	0.000863	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Docetaxel—ovarian cancer	0.000368	0.000862	CcSEcCtD
Dinoprost Tromethamine—Headache—Docetaxel—ovarian cancer	0.000366	0.000858	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—ovarian cancer	0.000362	0.000849	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—ovarian cancer	0.000359	0.00084	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—ovarian cancer	0.000356	0.000834	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—ovarian cancer	0.000354	0.000829	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000352	0.000826	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—ovarian cancer	0.000351	0.000823	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—ovarian cancer	0.00035	0.000821	CcSEcCtD
Dinoprost Tromethamine—Nausea—Docetaxel—ovarian cancer	0.000347	0.000813	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—ovarian cancer	0.000341	0.000798	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—ovarian cancer	0.000337	0.00079	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—ovarian cancer	0.000327	0.000767	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—ovarian cancer	0.000325	0.000762	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—ovarian cancer	0.000325	0.000761	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—ovarian cancer	0.000324	0.000759	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000322	0.000755	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—ovarian cancer	0.000312	0.000731	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—ovarian cancer	0.000311	0.00073	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—ovarian cancer	0.000311	0.00073	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.0003	0.000704	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000298	0.000699	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—ovarian cancer	0.00029	0.00068	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—ovarian cancer	0.000288	0.000675	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—ovarian cancer	0.000288	0.000675	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Epirubicin—ovarian cancer	0.000283	0.000662	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Epirubicin—ovarian cancer	0.000279	0.000653	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—ovarian cancer	0.00027	0.000632	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000269	0.000629	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—ovarian cancer	0.000261	0.000613	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—ovarian cancer	0.00026	0.000611	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—ovarian cancer	0.000258	0.000604	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—ovarian cancer	0.00025	0.000587	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000249	0.000584	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—ovarian cancer	0.000248	0.000582	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—ovarian cancer	0.000248	0.000582	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—ovarian cancer	0.000247	0.000578	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—ovarian cancer	0.000241	0.000565	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—ovarian cancer	0.000234	0.000548	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—ovarian cancer	0.000232	0.000543	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—ovarian cancer	0.00023	0.000539	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—ovarian cancer	0.00023	0.000538	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—ovarian cancer	0.000228	0.000535	CcSEcCtD
Dinoprost Tromethamine—Nausea—Doxorubicin—ovarian cancer	0.000216	0.000507	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APC—ovarian cancer	7.35e-05	0.000416	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CG—ovarian cancer	7.35e-05	0.000416	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—NRAS—ovarian cancer	7.35e-05	0.000416	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—ovarian cancer	7.21e-05	0.000408	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—ovarian cancer	7.21e-05	0.000408	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—ovarian cancer	7.18e-05	0.000406	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CD—ovarian cancer	7.17e-05	0.000405	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CTNNB1—ovarian cancer	7.14e-05	0.000404	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CB—ovarian cancer	7.13e-05	0.000403	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PIK3CA—ovarian cancer	7.1e-05	0.000401	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTEN—ovarian cancer	7.08e-05	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL2—ovarian cancer	7.06e-05	0.000399	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—ovarian cancer	7.06e-05	0.000399	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MAPK3—ovarian cancer	7.04e-05	0.000398	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—ovarian cancer	7.02e-05	0.000397	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—ovarian cancer	7e-05	0.000396	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CB—ovarian cancer	6.98e-05	0.000395	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CB—ovarian cancer	6.98e-05	0.000395	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTEN—ovarian cancer	6.96e-05	0.000394	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—ovarian cancer	6.86e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—ovarian cancer	6.86e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—ovarian cancer	6.79e-05	0.000384	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL8—ovarian cancer	6.71e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—ovarian cancer	6.71e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MAPK1—ovarian cancer	6.7e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—ovarian cancer	6.7e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL2—ovarian cancer	6.55e-05	0.00037	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TERT—ovarian cancer	6.53e-05	0.000369	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CD—ovarian cancer	6.47e-05	0.000366	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PIK3CA—ovarian cancer	6.45e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL2—ovarian cancer	6.41e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL2—ovarian cancer	6.41e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PIK3CA—ovarian cancer	6.4e-05	0.000362	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TERT—ovarian cancer	6.39e-05	0.000361	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TERT—ovarian cancer	6.39e-05	0.000361	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ERBB2—ovarian cancer	6.33e-05	0.000358	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—ovarian cancer	6.33e-05	0.000358	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—YAP1—ovarian cancer	6.32e-05	0.000357	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—ovarian cancer	6.29e-05	0.000356	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CB—ovarian cancer	6.25e-05	0.000353	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MTOR—ovarian cancer	6.25e-05	0.000353	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.24e-05	0.000353	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT3—ovarian cancer	6.23e-05	0.000352	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRAS—ovarian cancer	6.21e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—ovarian cancer	6.06e-05	0.000343	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CAV1—ovarian cancer	6.04e-05	0.000341	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL8—ovarian cancer	6e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—ovarian cancer	5.97e-05	0.000337	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	5.95e-05	0.000337	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK3—ovarian cancer	5.95e-05	0.000336	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CAV1—ovarian cancer	5.91e-05	0.000334	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CAV1—ovarian cancer	5.91e-05	0.000334	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1B—ovarian cancer	5.86e-05	0.000332	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ESR1—ovarian cancer	5.82e-05	0.000329	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PIK3CA—ovarian cancer	5.82e-05	0.000329	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—ovarian cancer	5.8e-05	0.000328	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MYC—ovarian cancer	5.79e-05	0.000327	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP3—ovarian cancer	5.75e-05	0.000325	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—ovarian cancer	5.74e-05	0.000324	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6ST—ovarian cancer	5.72e-05	0.000324	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ERBB2—ovarian cancer	5.71e-05	0.000323	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—ovarian cancer	5.71e-05	0.000323	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ESR1—ovarian cancer	5.69e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ESR1—ovarian cancer	5.69e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK1—ovarian cancer	5.66e-05	0.00032	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—ovarian cancer	5.66e-05	0.00032	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MTOR—ovarian cancer	5.64e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CB—ovarian cancer	5.64e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6ST—ovarian cancer	5.6e-05	0.000317	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6ST—ovarian cancer	5.6e-05	0.000317	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—ovarian cancer	5.59e-05	0.000316	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CTNNB1—ovarian cancer	5.54e-05	0.000313	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APC—ovarian cancer	5.5e-05	0.000311	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—ovarian cancer	5.5e-05	0.000311	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—ovarian cancer	5.5e-05	0.000311	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—ovarian cancer	5.43e-05	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL8—ovarian cancer	5.42e-05	0.000306	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—ovarian cancer	5.4e-05	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APC—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CG—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APC—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—ovarian cancer	5.38e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—ovarian cancer	5.35e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1B—ovarian cancer	5.29e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—ovarian cancer	5.27e-05	0.000298	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—ovarian cancer	5.27e-05	0.000298	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—ovarian cancer	5.23e-05	0.000296	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP3—ovarian cancer	5.18e-05	0.000293	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—ovarian cancer	5.18e-05	0.000293	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—ovarian cancer	5.16e-05	0.000292	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK3—ovarian cancer	5.16e-05	0.000292	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—FASN—ovarian cancer	5.15e-05	0.000291	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—ovarian cancer	5.15e-05	0.000291	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	5.07e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—ovarian cancer	5.05e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK1—ovarian cancer	5.01e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—ovarian cancer	5.01e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CTNNB1—ovarian cancer	5e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000282	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PIK3CA—ovarian cancer	4.91e-05	0.000278	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK1—ovarian cancer	4.91e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK1—ovarian cancer	4.91e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—ovarian cancer	4.9e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—ovarian cancer	4.9e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—ovarian cancer	4.9e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	4.89e-05	0.000277	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—ovarian cancer	4.88e-05	0.000276	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—ovarian cancer	4.87e-05	0.000275	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—ovarian cancer	4.83e-05	0.000273	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—ovarian cancer	4.83e-05	0.000273	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—ovarian cancer	4.82e-05	0.000272	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—ovarian cancer	4.79e-05	0.000271	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—ovarian cancer	4.78e-05	0.00027	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—ovarian cancer	4.75e-05	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—ovarian cancer	4.75e-05	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—ovarian cancer	4.73e-05	0.000268	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CD—ovarian cancer	4.73e-05	0.000268	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—ovarian cancer	4.73e-05	0.000268	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	4.69e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PIK3CA—ovarian cancer	4.69e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—ovarian cancer	4.69e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—ovarian cancer	4.63e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—ovarian cancer	4.63e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK3—ovarian cancer	4.61e-05	0.000261	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—ovarian cancer	4.54e-05	0.000257	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MYC—ovarian cancer	4.49e-05	0.000254	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—ovarian cancer	4.4e-05	0.000249	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK1—ovarian cancer	4.39e-05	0.000248	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—ovarian cancer	4.39e-05	0.000248	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—ovarian cancer	4.36e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—ovarian cancer	4.35e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—ovarian cancer	4.35e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—ovarian cancer	4.34e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—ovarian cancer	4.27e-05	0.000241	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—ovarian cancer	4.26e-05	0.000241	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CA—ovarian cancer	4.26e-05	0.000241	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—ovarian cancer	4.21e-05	0.000238	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MTOR—ovarian cancer	4.21e-05	0.000238	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ERBB2—ovarian cancer	4.18e-05	0.000236	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—ovarian cancer	4.18e-05	0.000236	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK3—ovarian cancer	4.16e-05	0.000235	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	4.16e-05	0.000235	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—ovarian cancer	4.15e-05	0.000234	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CB—ovarian cancer	4.12e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MTOR—ovarian cancer	4.12e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—ovarian cancer	4.12e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MTOR—ovarian cancer	4.12e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—ovarian cancer	4.08e-05	0.000231	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—ovarian cancer	4.05e-05	0.000229	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MYC—ovarian cancer	4.05e-05	0.000229	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—ovarian cancer	4.02e-05	0.000228	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—ovarian cancer	4.01e-05	0.000227	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL8—ovarian cancer	3.96e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—ovarian cancer	3.96e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK1—ovarian cancer	3.96e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—ovarian cancer	3.96e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1B—ovarian cancer	3.95e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—ovarian cancer	3.94e-05	0.000223	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—ovarian cancer	3.94e-05	0.000223	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—ovarian cancer	3.91e-05	0.000221	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP3—ovarian cancer	3.88e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1B—ovarian cancer	3.87e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1B—ovarian cancer	3.87e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—ovarian cancer	3.87e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ABCB1—ovarian cancer	3.86e-05	0.000218	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—ovarian cancer	3.85e-05	0.000218	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—ovarian cancer	3.83e-05	0.000217	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—ovarian cancer	3.83e-05	0.000217	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CA—ovarian cancer	3.81e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TYMS—ovarian cancer	3.79e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP3—ovarian cancer	3.79e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP3—ovarian cancer	3.79e-05	0.000215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—ovarian cancer	3.79e-05	0.000214	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—ovarian cancer	3.79e-05	0.000214	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—ovarian cancer	3.77e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—ovarian cancer	3.77e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—ovarian cancer	3.77e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—ovarian cancer	3.74e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—ovarian cancer	3.74e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—ovarian cancer	3.69e-05	0.000209	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—ovarian cancer	3.69e-05	0.000209	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—ovarian cancer	3.68e-05	0.000208	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—ovarian cancer	3.66e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CTNNB1—ovarian cancer	3.66e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—ovarian cancer	3.66e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—ovarian cancer	3.64e-05	0.000206	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—ovarian cancer	3.59e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—ovarian cancer	3.59e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—ovarian cancer	3.56e-05	0.000202	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—ovarian cancer	3.56e-05	0.000202	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—ovarian cancer	3.55e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—ovarian cancer	3.52e-05	0.000199	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—ovarian cancer	3.48e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—ovarian cancer	3.48e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CA—ovarian cancer	3.44e-05	0.000194	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—ovarian cancer	3.37e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—ovarian cancer	3.32e-05	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—ovarian cancer	3.29e-05	0.000186	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—ovarian cancer	3.26e-05	0.000184	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—ovarian cancer	3.25e-05	0.000184	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—ovarian cancer	3.22e-05	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—ovarian cancer	3.22e-05	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—ovarian cancer	3.19e-05	0.00018	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—ovarian cancer	3.19e-05	0.00018	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—ovarian cancer	3.18e-05	0.00018	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—ovarian cancer	3.18e-05	0.00018	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—ovarian cancer	3.18e-05	0.00018	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—ovarian cancer	3.11e-05	0.000176	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—ovarian cancer	3.11e-05	0.000176	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CAV1—ovarian cancer	3.06e-05	0.000173	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK3—ovarian cancer	3.05e-05	0.000172	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—ovarian cancer	3.05e-05	0.000172	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—ovarian cancer	3.04e-05	0.000172	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MYC—ovarian cancer	3.03e-05	0.000171	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MYC—ovarian cancer	2.96e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MYC—ovarian cancer	2.96e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK1—ovarian cancer	2.96e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—ovarian cancer	2.96e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK1—ovarian cancer	2.9e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK1—ovarian cancer	2.9e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—ovarian cancer	2.9e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—ovarian cancer	2.9e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—ovarian cancer	2.81e-05	0.000159	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—ovarian cancer	2.8e-05	0.000158	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	2.78e-05	0.000157	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—ovarian cancer	2.74e-05	0.000155	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—ovarian cancer	2.74e-05	0.000155	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—ovarian cancer	2.57e-05	0.000145	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CA—ovarian cancer	2.51e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—ovarian cancer	2.51e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—ovarian cancer	2.49e-05	0.000141	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	2.45e-05	0.000138	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—ovarian cancer	2.43e-05	0.000138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—ovarian cancer	2.43e-05	0.000138	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—ovarian cancer	2.38e-05	0.000134	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—ovarian cancer	2.33e-05	0.000132	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—ovarian cancer	2.33e-05	0.000132	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—ovarian cancer	2.27e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—ovarian cancer	2.23e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—ovarian cancer	2.23e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	2.13e-05	0.000121	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—ovarian cancer	2.1e-05	0.000119	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—ovarian cancer	2.05e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—ovarian cancer	2.05e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—ovarian cancer	1.84e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	1.3e-05	7.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—ovarian cancer	1.06e-05	6.01e-05	CbGpPWpGaD
